Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Classical hematology 1

Conditions

Thrombocytopenia 1Neutropenia 1Leukemia, Myelomonocytic, Acute 1Leukemia, Myeloid, Acute 1Leukemia, Monocytic, Acute 1Leukemia, Megakaryoblastic, Acute 1Leukemia, Erythroblastic, Acute 1Leukemia 1Anemia 1

Interventions

Cytarabine 24Busulfan 13Peripheral Blood Stem Cell Transplantation 11fludarabine phosphate 10Filgrastim 10Cyclophosphamide 10Cyclosporine 9Antilymphocyte Serum 9Idarubicin 8Mitoxantrone 7Methotrexate 7Etoposide 7Daunorubicin 7sargramostim 6Gemtuzumab 6Whole-Body Irradiation 5Radiotherapy 5tipifarnib 4alvocidib 4Azacitidine 4Vorinostat 3Tacrolimus 3Mycophenolic Acid 3Methylprednisolone 3Melphalan 3Flow Cytometry 3Cytogenetic Analysis 3Cyclosporins 3Clofarabine 3merphos 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Leukemia, Erythroblastic, Acute × leridistim × Clear all
NCT00004215 2013-06-19

Leridistim Compared With Filgrastim in Treating Older Patients With Acute Myeloid Leukemia

Memorial Sloan Kettering Cancer Center

Phase 2 Completed
Classical hematologyOther hematologic neoplasm

Anemia, Leukemia, Erythroblastic, Acute, Leukemia, Leukemia, Megakaryoblastic, Acute, Leukemia, Monocytic, Acute, Neutropenia, Thrombocytopenia, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡